Top Markets
#1 Siren Siren +39.12%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.65%
#3 Ocean Protocol Ocean Protocol +15.51%
#4 KUB Coin KUB Coin +15.08%
#5 Perle Perle +11.39%
#6 Audiera Audiera +11.03%
#7 Nockchain Nockchain +9.99%
#8 Geodnet Geodnet +9.30%
#9 Arowana Arowana +8.26%
#10 Wiki Cat Wiki Cat +8.24%
Coin of the day
Siren Siren
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
Rang in Aktien #32097
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Aktienkurs
$0.21483059
Zuletzt synchronisiert: 2024-05-07
Marktkapitalisierung
$11.13M
Veränderung (1 Tag)
0.34%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel Antibe Therapeutics Inc. (ATE)

Kategorie

Healthcare
Preis ATE mit Marktkapitalisierung von B
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
ATE
$0.21483059
Marktkapitalisierung von Antibe Therapeutics Inc.(ATE)
Marktkapitalisierung: $11.13M
Mit Stand August 2026 hat Antibe Therapeutics Inc. eine Marktkapitalisierung von $11.13M. Das macht Antibe Therapeutics Inc. laut unseren Daten zum 32097th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Antibe Therapeutics Inc. von 2013 bis 2026
ATE im Vergleich zu den Top 5 der beliebtesten stocks
Preis für ATE Vermögenswert B Marktkapitalisierung von B Ergebnisse
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$105,363 $11.13M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.460T +49,044,735.68%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$86,632.75 $11.13M
Apple Inc. Apple Inc.
AAPL
$4.489T +40,325,975.22%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$79,906.01 $11.13M
Alphabet Inc. Alphabet Inc.
GOOG
$4.141T +37,194,795.68%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$68,861.34 $11.13M
Microsoft Corporation Microsoft Corporation
MSFT
$3.569T +32,053,685.74%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$53,993.05 $11.13M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.798T +25,132,751.91%